Saghar Barati

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

Payam Tabarsi, Saghar Barati, Hamidreza Jamaati et al. · International Immunopharmacology · 2020 · 87 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +6

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari et al. · Clinical Microbiology and Infection · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari et al. · Clinical Microbiology and Infection · 2022 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari et al. · Immunology · 2022 · 41 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial

Atefeh Fakharian, Saghar Barati, Maryam Sadat Mirenayat et al. · International Immunopharmacology · 2021 · 34 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +7